According to the detection of the p21 levels in the plasma, urine, and organs of the AKI model, Johnson and Zager considered that plasma and urinary p21 can be potential biomarkers of AKI and renal aging [10]. This evidence concerns the gene CDKN1A and acute kidney injury.